Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure.


BACKGROUND Elevated total plasma homocysteine (tHcy) levels have been associated with vascular disease and higher mortality in patients with coronary artery disease. Graft coronary disease is a major cause of mortality in long-term survivors of heart transplantation, and hyperhomocysteinemia may be one of its causes. The objectives of our study were to… (More)


  • Presentations referencing similar topics